Br J Psychiatry
- FREEMAN D
Developing psychological treatments for psychosis.
Br J Psychiatry. 2024;224:147-149.
- FERNANDEZ-EGEA E, Chen S, Sanguesa E, Gasso P, et al
The role of psychosis and clozapine load in excessive checking in
treatment-resistant schizophrenia: longitudinal observational study.
Br J Psychiatry. 2024;224:164-169.
J Psychiatry Neurosci
-
Correction to "Improving causality perception judgments in schizophrenia spectrum
disorder via transcranial direct current stimulation".
J Psychiatry Neurosci. 2024;49:E144.
-
Correction to "Navigated and individual alpha-peak-frequency-guided transcranial
magnetic stimulation in male patients with treatment-refractory schizophrenia".
J Psychiatry Neurosci. 2024;49:E143.
Mol Psychiatry
- OKADA N, Fukunaga M, Miura K, Nemoto K, et al
Subcortical volumetric alterations in four major psychiatric disorders: a
mega-analysis study of 5604 subjects and a volumetric data-driven approach for
classification.
Mol Psychiatry. 2023;28:5206-5216.
- GRIECO SF, Johnston KG, Gao P, Garduno BM, et al
Anatomical and molecular characterization of parvalbumin-cholecystokinin
co-expressing inhibitory interneurons: implications for neuropsychiatric
conditions.
Mol Psychiatry. 2023;28:5293-5308.
- WEI W, Deng L, Qiao C, Yin Y, et al
Neural variability in three major psychiatric disorders.
Mol Psychiatry. 2023;28:5217-5227.
- KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
Selecting cases of major psychiatric and substance use disorders in Swedish
national registries on the basis of clinical features to maximize the strength or
specificity of the genetic risk.
Mol Psychiatry. 2023;28:5195-5205.
- ZHENG H, Webster MJ, Weickert CS, Beasley CL, et al
Cytomegalovirus antibodies are associated with mood disorders, suicide, markers
of neuroinflammation, and microglia activation in postmortem brain samples.
Mol Psychiatry. 2023;28:5282-5292.
Neuropsychopharmacology
- LIVINGSTON NR, Kiemes A, Devenyi GA, Knight S, et al
Effects of diazepam on hippocampal blood flow in people at clinical high risk for
psychosis.
Neuropsychopharmacology. 2024 Apr 24. doi: 10.1038/s41386-024-01864.
- PISANU C, Congiu D, Meloni A, Paribello P, et al
Dissecting the genetic overlap between severe mental disorders and markers of
cellular aging: Identification of pleiotropic genes and druggable targets.
Neuropsychopharmacology. 2024;49:1033-1041.
Psychiatry Res
- BRADLEY ER, Portanova J, Woolley JD, Buck B, et al
Quantifying abnormal emotion processing: A novel computational assessment method
and application in schizophrenia.
Psychiatry Res. 2024;336:115893.
Schizophr Res
- ALBEELY AM, Williams OOF, Blight CR, Theriault RK, et al
Sex differences in neuronal oscillatory activity and memory in the
methylazoxymethanol acetate model of schizophrenia.
Schizophr Res. 2024;267:451-461.
- LI H, Huang Y, Liang L, Li H, et al
The relationship between the gut microbiota and oxidative stress in the cognitive
function of schizophrenia: A pilot study in China.
Schizophr Res. 2024;267:444-450.
- LE BARS T, Bulteau S, Bonnot O, Gollier-Briant F, et al
Home-based transcranial direct current stimulation in schizophrenia: Systematic
literature review, a teenager case report with cost-utility analysis.
Schizophr Res. 2024;267:441-443.
- GOGOS A, Sbisa A, van den Buuse M
Disruption of NMDA receptor-mediated regulation of PPI in the maternal immune
activation model of schizophrenia is restored by 17beta-estradiol and raloxifene.
Schizophr Res. 2024;267:432-440.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016